Pages that link to "Q34625171"

The following pages link to Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer. (Q34625171):

Displaying 41 items.

• Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs (Q27726998) (← links)
• Recent advances and novel treatment paradigms in acute lymphocytic leukemia (Q28078076) (← links)
• Syk and tired of current chronic GVHD therapies (Q35784487) (← links)
• Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis (Q36281674) (← links)
• Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy. (Q36282920) (← links)
• Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances (Q38554422) (← links)
• Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify (Q38686339) (← links)
• DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. (Q38743845) (← links)
• MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. (Q40410579) (← links)
• DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. (Q41199050) (← links)
• Central role of PI3K-SYK interaction in fibrinogen-induced lamellipodia and filopodia formation in platelets (Q41779379) (← links)
• High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients. (Q42366278) (← links)
• Kinase-targeted cancer therapies: progress, challenges and future directions (Q49887882) (← links)
• Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products. (Q49887894) (← links)
• Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma (Q49952999) (← links)
• Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms. (Q50027146) (← links)
• Alternative Splicing as a Target for Cancer Treatment. (Q50033988) (← links)
• Suppression of Spleen Tyrosine Kinase (Syk) by Histone Deacetylation Promotes, Whereas BAY61-3606, a Synthetic Syk Inhibitor Abrogates Colonocyte Apoptosis by ERK Activation. (Q51706615) (← links)
• SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment. (Q52699628) (← links)
• [Spleen tyrosine kinase inhibits proliferation and promotes apoptosis of colorectal cancer cells in vitro via regulating Fra-1]. (Q54131701) (← links)
• Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer. (Q54977595) (← links)
• Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays. (Q54979889) (← links)
• [Expression of full-length spleen tyrosine kinase in the oral squamous cell carcinoma and its relationship with tumor invasion and metastasis]. (Q55033806) (← links)
• KISS1/KISS1R in Cancer: Friend or Foe? (Q57170895) (← links)
• miR-129-2-3p directly targets SYK gene and associates with the risk of ischaemic stroke in a Chinese population (Q60928169) (← links)
• R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells (Q64073150) (← links)
• SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro (Q64245695) (← links)
• Expression of Syk and MAP4 proteins in ovarian cancer (Q64280782) (← links)
• A rare malignant thyroid carcinosarcoma with aggressive behavior and DICER1 gene mutation: a case report with literature review. (Q64915391) (← links)
• Linking inflammation and cancer: the unexpected SYK world (Q88319182) (← links)
• Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation (Q89861185) (← links)
• Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors (Q90317373) (← links)
• Entropic allostery dominates the phosphorylation-dependent regulation of Syk tyrosine kinase release from immunoreceptor tyrosine-based activation motifs (Q90563189) (← links)
• Developing role of B cells in the pathogenesis and treatment of chronic GVHD (Q90751374) (← links)
• The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress (Q91132654) (← links)
• The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex (Q91816605) (← links)
• Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells (Q91943722) (← links)
• Identification of osteosarcoma driver genes using a network method (Q92835221) (← links)
• The Hidden Cost of Modern Medical Interventions: How Medical Advances Have Shaped the Prevalence of Human Fungal Disease (Q93105339) (← links)
• Monoglyceride lipase mediates tumor-suppressive effects by promoting degradation of X-linked inhibitor of apoptosis protein (Q94591519) (← links)
• HACS1 signaling adaptor protein recognizes a motif in the paired immunoglobulin receptor B cytoplasmic domain (Q102059166) (← links)